PRPH (ProPhase Labs Inc) Tingkat bathi reged

Simbol resmi perusahaan ProPhase Labs Corp (PRPH)

Stable turnover of over-the-counter brands supports ProPhase Labs, Inc. during periods of transformation. The core strategy focuses on the synthesis of genomic sequencing with Nebula Genomics AI platforms, creating high customer retention value. Gross profit margins confirm the impact of capacity underutilization during the transition to genomics. The value of 0.00 serves as the current metric level, capturing the real operational efficiency of management.

Rentabilitas reged ProPhase Labs (PRPH): kanggo periode 04.07.2022 - 10.01.2026

Rincian metrik komprehensif lan analitis ProPhase Labs, Inc. (PRPH)

- indikator valuasi pasar bisnis:
Analisis dhasar perusahaan:ProPhase Labs, PRPH
Produk mawa merek ProPhase Labs Corp

Gross margin measures the share of profit after deducting direct production costs, allowing for an assessment of operational efficiency and the business's ability to generate cash flow. For ProPhase Labs, Inc. (PRPH), diversification between laboratory diagnostics and genomic therapies stabilizes the gross profit margin, confirming the business model's resilience to industry cycles and serving as an indicator of the company's fundamental reliability.